PDB Short entry for 3Q95 HEADER TRANSCRIPTION REGULATOR 07-JAN-11 3Q95 TITLE CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH TITLE 2 GRIP PEPTIDE AND ESTRIOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN RESIDUES 298-554; COMPND 5 SYNONYM: ER, ER-ALPHA, ESTRADIOL RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY COMPND 6 3 GROUP A MEMBER 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ESTROGEN RECEPTOR; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: LXXLL MOTIF 2 RESIDUES 686-698; COMPND 13 SYNONYM: ER, ER-ALPHA, ESTRADIOL RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY COMPND 14 3 GROUP A MEMBER 1; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 3; COMPND 17 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 18 CHAIN: C, D; COMPND 19 SYNONYM: NCOA-2, CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 75, BHLHE75, COMPND 20 TRANSCRIPTIONAL INTERMEDIARY FACTOR 2, HTIF2; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ER ALPHA, ESR, ESR1, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMCSG7; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: ER ALPHA, ESR, ESR1, NR3A1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PMCSG7; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606; SOURCE 26 OTHER_DETAILS: SYNTHETIC PEPTIDE KEYWDS TRANSCRIPTIONAL REGULATOR, NUCLEAR RECEPTOR, TRANSCRIPTION REGULATOR EXPDTA X-RAY DIFFRACTION AUTHOR S.S.RAJAN,Y.KIM,K.VANEK,A.JOACHIMIAK,G.L.GREENE REVDAT 2 13-SEP-23 3Q95 1 REMARK SEQADV LINK REVDAT 1 11-JAN-12 3Q95 0 JRNL AUTH S.S.RAJAN,Y.KIM,K.VANEK,A.JOACHIMIAK,G.L.GREENE JRNL TITL CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LBD IN JRNL TITL 2 COMPLEX WITH GRIP PEPTIDE AND ESTRIOL JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 28260 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1500 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.11 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1548 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 70.38 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE SET COUNT : 87 REMARK 3 BIN FREE R VALUE : 0.2950 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4182 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 80 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.37000 REMARK 3 B22 (A**2) : -0.09000 REMARK 3 B33 (A**2) : -1.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.25000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.267 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.202 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.144 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.604 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4402 ; 0.011 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 3007 ; 0.006 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5964 ; 1.252 ; 1.997 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7405 ; 0.786 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 541 ; 7.358 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 183 ;33.513 ;23.825 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 843 ;13.563 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;19.951 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 704 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4686 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 822 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2647 ; 1.083 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1058 ; 0.290 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4285 ; 1.984 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1755 ; 3.260 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1669 ; 5.172 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 305 A 550 REMARK 3 ORIGIN FOR THE GROUP (A): 15.0271 3.8747 0.1030 REMARK 3 T TENSOR REMARK 3 T11: 0.0130 T22: 0.0063 REMARK 3 T33: 0.0159 T12: -0.0018 REMARK 3 T13: 0.0010 T23: 0.0058 REMARK 3 L TENSOR REMARK 3 L11: 1.2709 L22: 0.4666 REMARK 3 L33: 1.4936 L12: 0.1666 REMARK 3 L13: 0.1476 L23: 0.3301 REMARK 3 S TENSOR REMARK 3 S11: -0.0326 S12: 0.0098 S13: -0.0990 REMARK 3 S21: 0.0214 S22: 0.0046 S23: -0.0091 REMARK 3 S31: 0.0790 S32: 0.0082 S33: 0.0281 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 300 B 552 REMARK 3 ORIGIN FOR THE GROUP (A): 6.0836 4.5843 23.1630 REMARK 3 T TENSOR REMARK 3 T11: 0.0178 T22: 0.0131 REMARK 3 T33: 0.0149 T12: 0.0050 REMARK 3 T13: -0.0082 T23: -0.0074 REMARK 3 L TENSOR REMARK 3 L11: 0.7790 L22: 0.8143 REMARK 3 L33: 0.9155 L12: 0.3130 REMARK 3 L13: -0.4132 L23: -0.0743 REMARK 3 S TENSOR REMARK 3 S11: -0.0274 S12: -0.0197 S13: 0.0075 REMARK 3 S21: 0.0085 S22: -0.0169 S23: 0.0409 REMARK 3 S31: 0.0585 S32: -0.0244 S33: 0.0443 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 686 C 696 REMARK 3 ORIGIN FOR THE GROUP (A): 16.2778 -15.8078 -7.1902 REMARK 3 T TENSOR REMARK 3 T11: 0.4008 T22: 0.1063 REMARK 3 T33: 0.1571 T12: -0.0096 REMARK 3 T13: 0.0024 T23: -0.0410 REMARK 3 L TENSOR REMARK 3 L11: 17.9893 L22: 13.0303 REMARK 3 L33: 5.9731 L12: -8.0876 REMARK 3 L13: 2.3057 L23: 3.9756 REMARK 3 S TENSOR REMARK 3 S11: 0.3030 S12: 0.2121 S13: -1.4927 REMARK 3 S21: -0.2366 S22: -0.1406 S23: 0.5608 REMARK 3 S31: 1.0566 S32: -0.1334 S33: -0.1624 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 686 D 698 REMARK 3 ORIGIN FOR THE GROUP (A): -8.8341 16.8941 26.0805 REMARK 3 T TENSOR REMARK 3 T11: 0.0352 T22: 0.0719 REMARK 3 T33: 0.0133 T12: 0.0404 REMARK 3 T13: -0.0004 T23: 0.0022 REMARK 3 L TENSOR REMARK 3 L11: 10.7498 L22: 7.0678 REMARK 3 L33: 7.8153 L12: -2.2119 REMARK 3 L13: 1.5155 L23: -2.0445 REMARK 3 S TENSOR REMARK 3 S11: 0.2783 S12: -0.1109 S13: 0.0312 REMARK 3 S21: -0.2690 S22: -0.1655 S23: 0.1693 REMARK 3 S31: -0.2944 S32: -0.6498 S33: -0.1128 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3Q95 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JAN-11. REMARK 100 THE DEPOSITION ID IS D_1000063350. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-MAR-10 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53026 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.0 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 37.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.10 REMARK 200 R MERGE FOR SHELL (I) : 0.51000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1ZKY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M LITHIUM SULFATE MONOHYDRATE, 0.1 REMARK 280 M TRIS PH 8.5, 25% W/V POLYETHYLENE GLYCOL 3,350, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.93250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1970 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 295 REMARK 465 ASN A 296 REMARK 465 ALA A 297 REMARK 465 ILE A 298 REMARK 465 LYS A 299 REMARK 465 ARG A 300 REMARK 465 SER A 301 REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 SER B 295 REMARK 465 ASN B 296 REMARK 465 ALA B 297 REMARK 465 ILE B 298 REMARK 465 LYS B 299 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 465 SER C 697 REMARK 465 SER C 698 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 336 C - N - CA ANGL. DEV. = -15.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU B 408 75.77 -150.81 REMARK 500 ARG B 548 79.26 51.68 REMARK 500 LEU B 549 -158.92 -89.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG B 335 PRO B 336 47.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ESL B 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ESL A 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 555 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 703 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3Q97 RELATED DB: PDB DBREF 3Q95 A 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 3Q95 B 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 3Q95 C 686 698 UNP Q15596 NCOA2_HUMAN 686 698 DBREF 3Q95 D 686 698 UNP Q15596 NCOA2_HUMAN 686 698 SEQADV 3Q95 SER A 295 UNP P03372 EXPRESSION TAG SEQADV 3Q95 ASN A 296 UNP P03372 EXPRESSION TAG SEQADV 3Q95 ALA A 297 UNP P03372 EXPRESSION TAG SEQADV 3Q95 SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 3Q95 SER B 295 UNP P03372 EXPRESSION TAG SEQADV 3Q95 ASN B 296 UNP P03372 EXPRESSION TAG SEQADV 3Q95 ALA B 297 UNP P03372 EXPRESSION TAG SEQADV 3Q95 SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 260 SER ASN ALA ILE LYS ARG SER LYS LYS ASN SER LEU ALA SEQRES 2 A 260 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 3 A 260 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 4 A 260 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 5 A 260 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 6 A 260 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 7 A 260 HIS ASP GLN VAL HIS LEU LEU GLU CME ALA TRP LEU GLU SEQRES 8 A 260 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 9 A 260 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 10 A 260 ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL GLU ILE SEQRES 11 A 260 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 12 A 260 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 13 A 260 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 14 A 260 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 15 A 260 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 16 A 260 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 17 A 260 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 18 A 260 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 19 A 260 LYS CYS LYS ASN VAL VAL PRO LEU SER ASP LEU LEU LEU SEQRES 20 A 260 GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 B 260 SER ASN ALA ILE LYS ARG SER LYS LYS ASN SER LEU ALA SEQRES 2 B 260 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 3 B 260 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 4 B 260 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 5 B 260 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 6 B 260 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 7 B 260 HIS ASP GLN VAL HIS LEU LEU GLU CME ALA TRP LEU GLU SEQRES 8 B 260 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 9 B 260 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 10 B 260 ARG ASN GLN GLY LYS CME VAL GLU GLY MET VAL GLU ILE SEQRES 11 B 260 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 12 B 260 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 13 B 260 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 14 B 260 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 15 B 260 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 16 B 260 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 17 B 260 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 18 B 260 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 19 B 260 LYS CYS LYS ASN VAL VAL PRO LEU SER ASP LEU LEU LEU SEQRES 20 B 260 GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 C 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER SEQRES 1 D 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER MODRES 3Q95 CME A 381 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3Q95 CME B 381 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3Q95 CME B 417 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 381 10 HET CME B 381 16 HET CME B 417 10 HET ESL A 700 21 HET CL A 555 1 HET CL A 701 1 HET CL A 702 1 HET CL A 703 1 HET ESL B 700 21 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM ESL ESTRIOL HETNAM CL CHLORIDE ION HETSYN ESL 1,3,5(10)-ESTRATRIENE-3,16,17-TRIOL FORMUL 1 CME 3(C5 H11 N O3 S2) FORMUL 5 ESL 2(C18 H24 O3) FORMUL 6 CL 4(CL 1-) FORMUL 11 HOH *80(H2 O) HELIX 1 1 SER A 305 LEU A 310 5 6 HELIX 2 2 THR A 311 GLU A 323 1 13 HELIX 3 3 SER A 338 LYS A 362 1 25 HELIX 4 4 GLY A 366 LEU A 370 5 5 HELIX 5 5 THR A 371 MET A 396 1 26 HELIX 6 6 ARG A 412 LYS A 416 1 5 HELIX 7 7 MET A 421 ASN A 439 1 19 HELIX 8 8 GLN A 441 SER A 456 1 16 HELIX 9 9 LYS A 467 ALA A 493 1 27 HELIX 10 10 THR A 496 LYS A 531 1 36 HELIX 11 11 SER A 537 ALA A 546 1 10 HELIX 12 12 SER B 301 LEU B 310 5 10 HELIX 13 13 THR B 311 GLU B 323 1 13 HELIX 14 14 SER B 338 LYS B 362 1 25 HELIX 15 15 THR B 371 MET B 396 1 26 HELIX 16 16 ASN B 413 VAL B 418 5 6 HELIX 17 17 MET B 421 MET B 438 1 18 HELIX 18 18 GLN B 441 SER B 456 1 16 HELIX 19 19 GLY B 457 PHE B 461 5 5 HELIX 20 20 LYS B 472 ALA B 493 1 22 HELIX 21 21 THR B 496 LYS B 531 1 36 HELIX 22 22 SER B 537 ALA B 546 1 10 HELIX 23 23 LYS C 688 ASP C 696 1 9 HELIX 24 24 LYS D 688 ASP D 696 1 9 SHEET 1 A 2 LYS A 401 ALA A 405 0 SHEET 2 A 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 LINK C GLU A 380 N CME A 381 1555 1555 1.32 LINK C CME A 381 N ALA A 382 1555 1555 1.33 LINK C GLU B 380 N CME B 381 1555 1555 1.32 LINK C CME B 381 N ALA B 382 1555 1555 1.33 LINK C LYS B 416 N CME B 417 1555 1555 1.34 LINK C CME B 417 N VAL B 418 1555 1555 1.33 SITE 1 AC1 7 HOH B 18 LEU B 346 GLU B 353 LEU B 387 SITE 2 AC1 7 ARG B 394 HIS B 524 LEU B 525 SITE 1 AC2 8 HOH A 24 MET A 343 LEU A 346 GLU A 353 SITE 2 AC2 8 LEU A 387 ARG A 394 HIS A 524 LEU A 525 SITE 1 AC3 4 HOH A 7 HOH A 22 ARG A 352 ARG B 352 SITE 1 AC4 2 THR A 496 LEU A 497 SITE 1 AC5 2 ARG A 412 LYS A 416 CRYST1 56.528 81.865 58.886 90.00 111.13 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017690 0.000000 0.006836 0.00000 SCALE2 0.000000 0.012215 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018206 0.00000